Emerging periurethral bulking agents for female stress urinary incontinence: Is new necessarily better?

Current Urology Reports

Volumn 7, Issue 5, 2006, Pages 405-413

  Starkman, Jonathan S ^b   Scarpero, Harriette ^b   Dmochowski, Roger R ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BULKING AGENT; CARBON; COLLAGEN; COPOLYMER; DEXTRANOMER; ETHYLENE VINYL ACETATE COPOLYMER; ETHYLENE VINYL ALCOHOL COPOLYMER; FAT; GLUTARALDEHYDE CROSS LINKED BOVINE COLLAGEN; HYALURONIC ACID; HYALURONIC ACID DERIVATIVE; HYDROXYAPATITE; SILICONE; ZIRCONIUM DERIVATIVE;

CLINICAL TRIAL; COST BENEFIT ANALYSIS; EQUIPMENT DESIGN; HUMAN; IMPLANT; IMPLANTATION; MINIMALLY INVASIVE SURGERY; PATIENT SATISFACTION; PRACTICE GUIDELINE; QUALITY OF LIFE; REVIEW; STRESS INCONTINENCE; TREATMENT OUTCOME; URETHRA; URINARY TRACT SURGERY; URINE RETENTION;

ANIMALS; BIOCOMPATIBLE MATERIALS; CLINICAL TRIALS; FEMALE; HUMANS; INJECTIONS; URETHRA; URINARY INCONTINENCE, STRESS;

EID: 33845357910     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-006-0012-2     Document Type: Review

References (74)

1. Gasquet I, Tcherny-Lessenot S, Gaudebout P, et al.: Influence of the severity of stress urinary incontinence on quality of life, health care seeking, and treatment: a national cross-sectional survey. Eur Urol 2006, in press.
2. Subak LL, Brown JS, Kraus SR, et al.: The "costs" of urinary incontinence for women. Obstet Gynecol 2006, 107:908-916.
3. Lightner DJ, Itano NB, Sweat SD, et al.: Injectable agents: present and future. Curr Urol Rep 2002, 3:408-413.
4. Corcos J, Collet JP, Shapiro S, et al.: Multicenter, randomized clinical trial comparing surgery and collagen injections for treatment of female stress urinary incontinence. Urology 2005, 65:898-904. Important recent article evaluating the role of bulking agents in women considering surgery.
5. Murless BC: The injection treatment of stress incontinence. J Obstet Gynaecol Br Emp 1938, 45:521-524.
6. Quackles R: Deux incontinences apres adenomectomie gueries par injection de paraffine dans le perinee. Acta Urol Belg 1955, 23:259-262.
7. Sachse S: Treatment of urinary incontinence with sclerosing solutions: indications, results, complications. Urol Int 1963, 15:225-229.
8. Politano VA, Small MP, Harper JM, Lynne CM: Periurethral teflon injection for urinary incontinence. J Urol 1974, 111:180-183.
9. van Kerrebroeck P, ter Meulen F, Farrelly E, et al.: Treatment of stress urinary incontinence: recent developments in the role of urethral injection. Urol Res 2003, 30:356-362.
10. Dmochowski R, Appell RA: Advancements in minimally invasive treatments for female stress urinary incontinence: radiofrequency and bulking agents. Curr Urol Rep 2003, 4:350-355.
11. Itano NB, Sweat SD, Lightner DJ: The use of bulking agents for stress incontinence. AUA Update Series 2002, XXI:34-39.
12. Yokoyama T, Huard J, Chancellor MB: Myoblast therapy for stress urinary incontinence and bladder dysfunction. World J Urol 2000, 18:56-61.
13. Leach GE, Dmochowski RR, Appell RA, et al.: Female Stress Urinary Incontinence Clinical Guidelines Panel summary report on surgical management of female stress urinary incontinence. The American Urological Association. J Urol 1997, 158:875-880.
14. Winters JC, Appell R: Periurethral injection of collagen in the treatment of intrinsic sphincteric deficiency in the female patient. Urol Clin North Am 1995, 22:673-678.
15. Monga AK, Stanton SL: Urodynamics: prediction, outcome, and analysis of mechanism for cure of stress incontinence by periurethral collagen. Br J Obstet Gynaecol 1997, 104:158-162.
16. Corcos J, Fournier C: Periurethral collagen injection for the treatment of female stress urinary incontinence: 4-year follow-up results. Urology 1999, 54:815-818.
17. Elsergany R, Ghoniem GM: Collagen injection for intrinsic sphincteric deficiency in men: a reasonable option in selected patients. J Urol 1998, 159:1504-1506.
18. Faerber GJ: Endoscopic collagen injection therapy in elderly women with type I stress urinary incontinence. J Urol 1996, 155:512-514.
19. Eckford SD, Abrams P: Para-urethral collagen implantation for female stress incontinence. Br J Urol 1991, 68:586-589.
20. Kieswetter H, Fischer M, Wober L, Flamm J: Endoscopic implantation of collagen (GAX) for the treatment of urinary incontinence. Br J Urol 1992, 69:22-25.
21. Monga AK, Robinson D, Stanton SL: Periurethral collagen injections for genuine stress incontinence: a 2-year follow-up. Br J Urol 1995, 76:156-160.
22. O'Connell HE, McGuire EJ, Aboseif S, Usui A: Transurethral collagen therapy in women. J Urol 1995, 154:1463-1465.
23. Blaivas JG, Olsson CA: Stress incontinence: classification and surgical approach. J Urol 1988, 139:727-731.
24. McGuire EJ, Lytton B, Kohorn EI, Pepe V: The value of urodynamic testing in stress urinary incontinence. J Urol 1980, 124:256-258.
25. English SF, Amundsen CL, McGuire EJ: Bladder neck competency at rest in women with incontinence. J Urol 1999, 161:578-580.
26. Steele AC, Kohli N, Karram MM: Periurethral collagen injection for stress incontinence with and without urethral hypermobility. Obstet Gynecol 2000, 95:327-331.
27. Herschorn S, Radomski SB: Collagen injections for genuine stress urinary incontinence: patient selection and durability. Int Urogynecol J Pelvic Floor Dysfunct 1997, 8:18-24.
28. Contigen® Bard® Collagen Implant (Package Insert). Covington, GA: CR Bard; 1998.
29. Kershen RT, Atala A: New advances in injectable therapies for the treatment of incontinence and vesicoureteral reflux. Urol Clin North Am 1999, 26:81-94, viii.
30. Kligman AM, Armstrong RC: Histologic response to intradermal Zyderm and Zyplast (glutaraldehyde cross-linked) collagen in humans. J Dermatol Surg Oncol 1986, 12:351-357.
31. Stegman SJ: Injectable collagen. Plast Reconstr Surg 1987, 80:866.
32. Stegman SJ, Chu S, Bensch K, Armstrong R: A light and electron microscopic evaluation of Zyderm collagen and Zyplast implants in aging human facial skin: a pilot study. Arch Dermatol 1987, 123:1644-1649.
33. Kershen RT, Dmochowski RR, Appell RA: Beyond collagen: injectable therapies for the treatment of female stress urinary incontinence in the new millennium. Urol Clin North Am 2002, 29:559-574.
34. Agency for Health Care Policy and Research: Clinical Practice Guidelines. Urinary Incontinence in Adults. Rockville, MD: Department of Health and Human Services; 1996.
35. Dmochowski RR, Appell RA: Injectable agents in the treatment of stress urinary incontinence in women: Where are we now? Urology 2000, 56(suppl 1):32-40.
36. Cross CA, English SF, Cespedes RD, McGuire EJ: A follow-up on transurethral collagen injection therapy for urinary incontinence. J Urol 1998, 159:106-108.
37. Khullar V, Cardozo LD, Abbott D, Anders K: GAX collagen in the treatment of urinary incontinence in elderly women: a 2-year follow up. Br J Obstet Gynaecol 1997, 104:96-99.
38. Winters JC, Chiverton A, Scarpero HM, Prats LJ Jr: Collagen injection therapy in elderly women: long-term results and patient satisfaction. Urology 2000, 55:856-861.
39. Stothers L, Goldenberg SL, Leone EF: Complications of periurethral collagen injection for stress urinary incontinence. J Urol 1998, 159:806-807.
40. Santarosa RP, Blaivas JG: Periurethral injection of autologous fat for the treatment of sphincteric incontinence. J Urol 1994, 151:607-611.
41. Haab F, Zimmern PE, Leach GE: Urinary stress incontinence due to intrinsic sphincteric deficiency: experience with fat and collagen periurethral injections. J Urol 1997, 157:1283-1286.
42. Lee PE, Kung RC, Drutz HP: Periurethral autologous fat injection as treatment for female stress urinary incontinence: a randomized, double-blind, controlled trial. J Urol 2001, 165:153-158.
43. Pannek J, Brands FH, Senge T: Particle migration after transurethral injection of carbon coated beads for stress urinary incontinence. J Urol 2001, 166:1350-1353.
44. Madjar S, Covington-Nichols C, Secrest CL: New periurethral bulking agent for stress urinary incontinence: modified technique and early results. J Urol 2003, 170:2327-2329.
45. Lightner D, Calvosa C, Andersen R, et al.: A new injectable bulking agent for treatment of stress urinary incontinence: results of a multicenter, randomized, controlled, double-blind study of Durasphere. Urology 2001, 58:12-15.
46. Chrouser KL, Fick F, Goel A, et al.: Carbon coated zirconium beads in beta-glucan gel and bovine glutaraldehyde cross-linked collagen injections for intrinsic sphincter deficiency: continence and satisfaction after extended follow-up. J Urol 2004, 171:1152-1155. Long-term durability trial results of initial registration study for carbon-coated zirconium beads.
47. Ghoniem GM, Khater U: Urethral prolapse after durasphere injection. Int Urogynecol J Pelvic Floor Dysfunct 2006, 17:297-298.
48. Radley SC, Chapple CR, Lee JA: Transurethral implantation of silicone polymer for stress incontinence: evaluation of a porcine model and mechanism of action in vivo. BJU Int 2000, 85:646-650.
49. Henly DR, Barrett DM, Weiland TL, et al.: Particulate silicone for use in periurethral injections: local tissue effects and search for migration. J Urol 1995, 153:2039-2043.
50. Henalla SM, Hall V, Duckett JR, et al.: A multicentre evaluation of a new surgical technique for urethral bulking in the treatment of genuine stress incontinence. BJOG 2000, 107:1035-1039.
51. Tamanini JT, D'Ancona CA, Tadini V, Netto NR Jr: Macroplastique implantation system for the treatment of female stress urinary incontinence. J Urol 2003, 169:2229-2233.
52. Harriss DR, Iacovou JW, Lemberger RJ: Peri-urethral silicone microimplants (Macroplastique) for the treatment of genuine stress incontinence. Br J Urol 1996, 78:722-728.
53. Usman F, Henalla S: A single transurethral Macroplastique injection as primary treatment for stress incontinence in women. J Obstet Gynaecol 1998, 18:56-60.
54. Sheriff MK, Foley S, McFarlane J, et al.: Endoscopic correction of intractable stress incontinence with silicone micro-implants. Eur Urol 1997, 32:284-288.
55. Maher CF, O'Reilly BA, Dwyer PL, et al.: Pubovaginal sling versus transurethral Macroplastique for stress urinary incontinence and intrinsic sphincter deficiency: a prospective, randomized, controlled trial. BJOG 2005, 112:797-801. Randomized trial evaluating bulking strategies compared with surgical intervention.
56. Drobeck HP, Rothstein SS, Gumaer KI, et al.: Histologic observation of soft tissue responses to implanted, multifaceted particles and discs of hydroxylapatite. J Oral Maxillofac Surg 1984, 42:143-149.
57. Misiek DJ, Kent JN, Carr RF: Soft tissue responses to hydroxylapatite particles of different shapes. J Oral Maxillofac Surg 1984, 42:150-160.
58. Pettis GY, Kaban LB, Glowacki J: Tissue response to composite ceramic hydroxyapatite/demineralized bone implants. J Oral Maxillofac Surg 1990, 48:1068-1074.
59. Mayer R, Lightfoot M, Jung I: Preliminary evaluation of calcium hydroxylapatite as a transurethral bulking agent for stress urinary incontinence. Urology 2001, 57:434-438.
60. Lightner DJ: Review of the available urethral bulking agents. Curr Opin Urol 2002, 12:333-338.
61. Solomon LZ, Birch BR, Cooper AJ, et al.: Nonhomologous bioinjectable materials in urology: 'size matters'? BJU Int 2000, 85:641-645.
62. Dmochowski RR, Appell RA, Klimberg I, Mayer R: Initial clinical results from coaptite injection for stress urinary incontinence comparative clinical study. Presented at the International Continence Society 32nd Annual Meeting. Heidelberg, Germany: August 28-30, 2002.
63. Mayer RD, Appell RA, Dmochowski RR: A 52-week trial of calcium hydroxylapatite vs. bovine dermal collagen for treatment of stress urinary incontinence. Presented at the Society of Female Urology and Urodynamics Annual Meeting. Grand Bahamas: February 22-26, 2006.
64. Palma PC, Riccetto CL, Martins MH, et al.: Massive prolapse of the urethral mucosa following periurethral injection of calcium hydroxylapatite for stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2005:1-2 [Epub ahead of print].
65. Dmochowski RR, Appell RA, Bent AE, et al.: Multicenter, randomized, controlled study to evaluate Uryx urethral bulking agent in treating female stress urinary incontinence. Presented at the American Urological Association Annual Meeting. San Francisco: May 8-13, 2004.
66. Tegress Urethral Implant, Package Insert. Covington, GA: Bard; 2005.
67. Stenberg A, Larsson E, Lindholm A, et al.: Injectable dextranomer-based implant: histopathology, volume changes and DNA-analysis. Scand J Urol Nephrol 1999, 33:355-361.
68. Lackgren G, Wahlin N, Skoldenberg E, Stenberg A: Long-term follow-up of children treated with dextranomer/hyaluronic acid copolymer for vesicoureteral reflux. J Urol 2001, 166:1887-1892.
69. Lackgren G, Wahlin N, Stenberg A: Endoscopic treatment of children with vesico-ureteric reflux. Acta Paediatr Suppl 1999, 88:62-71.
70. Stenberg AM, Sundin A, Larsson BS, et al.: Lack of distant migration after injection of a 125iodine labeled dextranomer based implant into the rabbit bladder. J Urol 1997, 158:1937-1941.
71. van Kerrebroeck P, ter Meulen F, Larsson G, et al.: Efficacy and safety of a novel system (NASHA/Dx copolymer using the Implacer device) for treatment of stress urinary incontinence. Urology 2004, 64:276-281.
72. van Kerrebroeck P, ter Meulen F, Larsson G, et al.: Treatment of stress urinary incontinence using a copolymer system: impact on quality of life. BJU Int 2004, 94:1040-1043. Analysis of quality-of-life impact of bulking therapy in patients receiving a new bulking agent.
73. Chapple CR, Haab F, Cervigni M, et al.: An open, multicentre study of NASHA/Dx Gel (Zuidex) for the treatment of stress urinary incontinence. Eur Urol 2005, 48:488-494. Multcentric trial of a new agent, using active comparator randomization.
74. Stenberg AM, Larsson G, Johnson P: Urethral injection for stress urinary incontinence: long-term results with dextranomer/hyaluronic acid copolymer. Int Urogynecol J Pelvic Floor Dysfunct 2003, 14:335-338.